MENLO PARK, Calif.--(BUSINESS WIRE)--June 22, 2006--Geron Corporation (Nasdaq:GERN - News) announced today that they have entered into a collaboration and license agreement with Corning Incorporated (NYSE:GLW - News) for the development and commercialization of synthetic surface matrices for the growth of human embryonic stem cells (hESCs).
